REGN is now in the
S&P 500

Regeneron is a science-driven large capitalization biotechnology company. Learn more here.

Attend

Attend the Annual Meeting of Shareholders June 14, 2013.
See Upcoming Events, below, for details.

Close
Form content here please :)